Transcript levels of PGC-1α have been reported to be markedly lower in mouse models of muscle atrophy induced by obesity, diabetes, or denervation [24,37,38], whereas energy restriction or leptin administration enhances skeletal muscle PGC-1α expression in rodents and humans [38,39]. Here, PPARGC1A is linked to obesity disorder.